Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
Recruiting
1,152 enrolled
Clinical Genetics Branch Eligibility Screening Survey
Not yet recruiting
1,000 enrolled
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitation
64,277 enrolled
HELIOPREDICT
Recruiting
700 enrolled
ctDNA for Risk Stratification in Melanoma
Active not recruiting
296 enrolled
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
7,000 enrolled
Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
Enrolling by invitation
1,150 enrolled
National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
TraveraRTGx
Completed
72 enrolled
UK-EnBiRiM
Active not recruiting
50 enrolled
SHERLOCK
Recruiting
7,000 enrolled
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recruiting
2,000 enrolled
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
Completed
25 enrolled 13 charts
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
Withdrawn
DP-04
Recruiting
100 enrolled
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
Completed
24 enrolled
COSMIC
Recruiting
2,000 enrolled
LEGIT_MC_EVCDA
Completed
105 enrolled 15 charts
PRO-ACTIVE
Recruiting
850 enrolled
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Recruiting
3,000 enrolled
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting
500 enrolled
Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and Melanoma
Active not recruiting
1,122 enrolled
IMMUMELA
Completed
217 enrolled
Clinical and Functional Retinal Changes Associated With BRAF/MEK Inhibitor Therapy in Patients With Malignant Melanoma
Completed
14 enrolled
PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor
Not yet recruiting
40 enrolled
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Recruiting
12,000 enrolled
Project: Every Child for Younger Patients With Cancer
Recruiting
75,000 enrolled
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
Active not recruiting
126 enrolled
FIBIOME
Not yet recruiting
60 enrolled
LegitHealth PH
Completed
9 enrolled
LegitHealthSAN
Completed
16 enrolled
Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers
Completed
131 enrolled
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Recruiting
100 enrolled
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection
Active not recruiting
78 enrolled
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
Active not recruiting
12 enrolled
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
Recruiting
1,000 enrolled
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Active not recruiting
72 enrolled
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App
Recruiting
100 enrolled
SJFAMILY
Recruiting
1,500 enrolled
Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
Completed
187 enrolled
EVpredict
Not yet recruiting
378 enrolled
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
Completed
5 enrolled
IMPACT
Recruiting
80 enrolled
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
Recruiting
30 enrolled
iCaRe2
Recruiting
999,999 enrolled
COPERGRAM1
Not yet recruiting
40 enrolled
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
Recruiting
24 enrolled